Consensus EPS · Q2 2026
$2.20
Consensus revenue · Q2 2026
$1.7B
Analysts
19
Expected report
Jul 21, 2026
What to watch
- Analyst ratings: Mixed
Think you can beat Wall Street?
Predict Equifax (EFX) Q2 2026 revenue & EPS, earn XP, and climb the leaderboard.
Analyst consensus
Based on estimates from 19 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $1.7B | $1.7B | $1.7B |
| EPS | $2.15 | $2.20 | $2.25 |
| EBITDA | $523.6M | $526.8M | $533M |
| EBIT | $332.7M | $334.7M | $338.7M |
| Net income | $256.6M | $266.1M | $300.4M |
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Equifax (EFX) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 0 analysts.
| Low | Consensus | Median | High | Current | Upside |
|---|---|---|---|---|---|
| $195.00 | $227.60 | $222.00 | $265.00 | $165.13 | +37.8% |
Upside calculated vs most recent trading price of $165.13.
Analyst ratings
Consensus: Buy — based on 34 analyst ratings.
12-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 19, 2026 | B of A Securities | maintain | Buy | Buy |
| Apr 27, 2026 | Needham | maintain | Buy | Buy |
| Apr 23, 2026 | UBS | maintain | Buy | Buy |
| Apr 22, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Apr 22, 2026 | Needham | maintain | Buy | Buy |
| Apr 22, 2026 | Baird | maintain | Outperform | Outperform |
| Apr 13, 2026 | UBS | maintain | Buy | Buy |
| Feb 9, 2026 | Goldman Sachs | maintain | Neutral | Neutral |
| Feb 5, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Feb 5, 2026 | Stifel | maintain | Buy | Buy |
Equifax (EFX) Key Financials
Charts, filings, and peer comparison for every metric
Frequently asked questions
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation